|
Affiliation |
Faculty of Medicine College Hospital Clinical training center after [sotsu] |
|
Title |
Assistant Professor |
|
External Link |
|
SUZUKI Sho
|
|
|
Papers 【 display / non-display 】
-
A novel endoscopic submucosal dissection training model using skinned chicken meat with gel.
Suzuki S, Kawakami H, Miike T, Ishikawa Y, Hirata T, Ichinari N, Komura A
Endoscopy 2020.11
Language：Japanese Publishing type：Research paper (scientific journal)
DOI： 10.1055/a-1287-8567
-
Complete Remission of Colon Cancer with Ipilimumab Monotherapy.
Suzuki S, Kawakami H, Miike T, Yamamoto S
Internal medicine (Tokyo, Japan) 2020.10
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：一般社団法人 日本内科学会
-
Single Rectal Neuroendocrine Tumor Associated with Multiple Endocrine Cell Micronests
Suzuki S., Kawakami H., Miike T., Yamamoto S., Abe H., Shimoda K., Ashizuka S., Inatsu H., Kubota Y., Ban T., Yorita K., Kataoka H.
Internal Medicine 59 ( 5 ) 619 - 623 2020.3
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Internal Medicine
© 2020 Japanese Society of Internal Medicine. All rights reserved. Although a few reports of neuroendocrine tumor (NET) in the stomach or appendix with surrounding micronests have been published, cases of rectal NET are rare. We herein report a unique case of a patient with single rectal NET treated endoscopically. A pathological examination revealed multiple endocrine cell micronests (ECMs) in the submucosal layer around the main NET lesion. Neither lymph node metastasis nor distant metastasis in computed tomography was observed six years after the treatment. Because case reports of multiple ECM are very rare, the significance of malignancy is unclear. It therefore appears to be necessary to accumulate similar cases.
-
Nemoto D., Suzuki S., Mori H., Katsuki S., Iwaki T., Aizawa M., Takeuchi Y., Uraoka T., Matsuda T., Fujita T., Hewett D.G., Togashi K.
Gastroenterological Endoscopy 62 ( 2 ) 210 - 219 2020.2
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Gastroenterological Endoscopy
© 2020 Japan Gastroenterological Endoscopy Society. All rights reserved. Objectives: Colonic spasm can interfere with colonoscopy, but antispasmodic agents can cause complications. This study aimed to assess the inhibitory effect of topical lidocaine compared with a placebo control. Methods: In five tertiary-care hospitals in Japan, 128 patients requiring endoscopic resection of a colorectal lesion were enrolled and randomly and double-blindly allocated to colonoscopy with topical administration of 2% lidocaine solution 20mL (LID, n=64) or normal saline 20mL (control, n=64). During colonoscopy, the assigned solution was applied with a spray catheter near the lesion and the area was observed for three minutes. Primary endpoint was the inhibitory effect at three time-points (1, 2 and 3 minutes after dispersion), using a three-point scale (excellent, fair, poor). Secondary endpoints were rebound spasm and adverse events. All endpoints were scored in real time. Serum lidocaine levels were measured in 32 patients (LID 16, control 16). Results: There were no significant differences between groups in patient demographics. At all time-points, the proportion of patients with “excellent” scores was greater in LID group than control group, with significant differences observed at 2 minutes (p=0.02) and 3 minutes (p=0.02). In LID group, the rate of “excellent” scores increased by 12.5% at 2 minutes and was maintained at 3 minutes. Rebound spasm did not occur in LID group, compared with 15.6% of control group (p=0.001). There were no adverse events in LID group. All serum lidocaine levels were below detectable levels. Conclusions: Topical lidocaine is an effective and safe method for suppressing colorectal spasm during colonoscopy (UMIN000024733).
DOI： 10.11280/gee.62.210
-
Shichijo S., Uedo N., Kanesaka T., Ohta T., Nakagawa K., Shimamoto Y., Ohmori M., Arao M., Iwatsubo T., Suzuki S., Matsuno K., Iwagami H., Inoue S., Matsuura N., Maekawa A., Nakahira H., Yamamoto S., Takeuchi Y., Higashino K., Ishihara R., Fukui K., Ito Y., Narahara H., Ishiguro S., Iishi H.
Journal of Gastroenterology and Hepatology (Australia) 2020
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Journal of Gastroenterology and Hepatology (Australia)
© 2020 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd Background and Aim: Endoscopic resection for early gastric cancer (EGC) is widely performed. However, there is still a paucity of strong evidence regarding long-term outcomes after endoscopic submucosal dissection (ESD) for the expanded indication criteria of the Japanese guidelines (ver. 2010). Methods: Endoscopic submucosal dissection was performed in patients with EGC that met the expanded indication criteria: (i) cT1a, differentiated-type EGC of 2 to 5 cm, ulcer negative or (ii) cT1a, differentiated-type EGC of ≤3 cm, ulcer positive. Patients whose pathological examination fulfilled the curative resection criteria were then enrolled in this cohort study: negative vertical margin, negative lymphovascular invasion, and (i) pT1a, differentiated-type, and ulcer negative; (ii) pT1a, differentiated-type, ≤3 cm, and ulcer positive; or (iii) pT1b1 (<500-μm submucosal invasion), differentiated-type, and ≤3 cm. Patients with only a positive horizontal margin as a noncurative factor were included for follow-up. Results: From September 2003 to February 2012, a total of 356 patients underwent ESD, and 214 were enrolled in the survival analysis. One hundred twenty patients (56%) had >2 cm in diameter and ulcer-negative lesions, and 94 (44%) had ≤3 cm and ulcer-positive lesions. The vital status at 5 years after ESD was confirmed in all (100%) patients. No local or metastatic recurrence was detected; however, 26 metachronous gastric cancers developed, and 1 patient died of metachronous gastric cancer. The 5-year disease-specific and overall survival rates were 99.5% (95% confidence interval [CI], 97.2%–100%) and 93.9% (95% CI, 89.8%–96.4%), respectively. Conclusion: ESD for EGC that fulfills the expanded criteria is feasible and shows favorable long-term outcomes.
DOI： 10.1111/jgh.15182
Books 【 display / non-display 】
-
H. pylori未感染胃上皮性腫瘍の臨床的特徴
鈴木 翔，上堂 文也，河上 洋，石原 立（ Role： Joint author）
医学書院 2020.7
Total pages：981-987 Responsible for pages：981-987 Language：Japanese Book type：General book, introductory book for general audience
MISC 【 display / non-display 】
-
Hepatic portal venous gas following colonic endoscopic submucosal dissection
Suzuki S., Takeuchi Y., Ishihara R., Kawakami H.
Internal Medicine 58 ( 5 ) 755 - 756 2019.3
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (bulletin of university, research institution) Publisher：Internal Medicine
Presentations 【 display / non-display 】
-
高齢者における食道ESD非高齢者同様に安全である
鈴木 翔, 三池 忠, 貴島 翔子, 米澤 瑛美, 坂元 一樹 平田 智也, 野田 貴穂, 安倍 弘生, 田原 良博, 山本 章二朗, 河上 洋
第 98 回消化器内視鏡学会
Event date： 2019.11.21
Language：Japanese Presentation type：Oral presentation (general)
-
Inhibitory Effect of Lidocaine on Colonic Spasm during Colonoscopy: A Multicenter Double-Blind, Randomized Controlled Trial
Event date： 2018.5.11
Language：English Presentation type：Symposium, workshop panel (public)